This innovative approach leverages the metabolic properties of tumors to transform lactate, a key immunosuppressive metabolite, into a therapeutic asset through a series of catalytic reactions, thereby enhancing pyroptosis‐STING coordination and ultimately achieving superior tumor control, offering new insights into tumor therapy. The gene discussed is STING1; the disease is neoplasm.